Company Intelligence Profile
Mchemist Global Private Limited
mChemist Global Pvt Ltd operates "mChemist" (mchemist.com), an online pharmacy / medicine-delivery platform.
Last updated 20 August 2026
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | Mchemist Global Private Limited |
|---|---|
| CIN | U52100DL2014PTC273913 |
| PAN | Not available in the public sources reviewed. |
| Status | Active (Active Compliant) |
| Listing | Unlisted private company |
| Incorporated | 09 December 2014 |
| ROC | Registrar of Companies, Delhi |
| Sector (NIC) | NIC 521 — Retail trade (non-specialized stores) / E-commerce, online healthcare-product retail (Main Activity Group G - Trade; Business Activity G2 - Retail Trading). Per Tofler business description: "Orthopedic, Ayurveda & Herbs, Diabetes, Protein & Supplements, Health Devices, Wellness." |
| Registered address | Plot No. 24 & 30, 2nd Floor, Okhla Phase 3, South Delhi, Okhla, Delhi, India – 110020 |
| Authorized capital | ₹3.0 Crore |
| Paid-up capital | ₹2.25 Crore |
Business Overview
Confirmed- mChemist Global Pvt Ltd operates "mChemist" (mchemist.com), an online pharmacy / medicine-delivery platform
- Product categories include Orthopedic, Ayurveda & Herbs, Diabetes care, Protein & Supplements, Health Devices, and Wellness products
- The company is DPIIT-recognised as a startup
- Source: Tofler, TheCompanyCheck
Directors
Partial / conflictingConfirmed (2 sources agree on names; DINs only from Tofler, not obtained/verified against MCA):
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Amit Kumar | 08437987 | Director, DIN 08437987 Tofler; appointed 21 Jan 2022, tenure ~5 years TheCompanyCheck: 4y6m | 21 Jan 2022 |
| Subash Prasar | 07616190 | Director, DIN 07616190 Tofler; appointed 03 Jan 2025, tenure ~1y7m TheCompanyCheck | 03 Jan 2025 |
Financials
Partial / conflictingPartial/conflicting-year data, not directly comparable (different FYs):
- Tofler: FY ending 31 March 2022 — Operating revenue range ₹1 Cr–₹100 Cr (broad bracket, not exact); Borrowings up 73.46% YoY; Assets up 25.85% YoY; ROCE 178.46%; Debt-to-Equity -0.25. Detailed P&L figures locked behind Pro subscription.
- TheCompanyCheck: FY 2025 (Balance Sheet date 31 March 2025) — Revenue ₹1.53 Crore (up 18.00% YoY implies FY2024 revenue ~₹1.30 Cr). EBITDA and Net Profit locked/premium, not obtained.
- Standalone vs consolidated: not specified by either source (entity appears to have no disclosed subsidiaries, so likely standalone).
- Auditor: A G A R AND ASSOCIATES.
No net worth figure obtained.
Charges / Borrowings
ConfirmedNo charges or secured borrowings are registered against this company's assets.
Competitors
Partial / conflicting1mg/Tata 1mg (large, Tata-backed), PharmEasy (large, well-funded), NetMeds/Reliance NetMeds (large, Reliance-backed), Apollo 24|7 (large, hospital-chain backed), Medlife (mid, since merged into PharmEasy), Truemeds (mid, growth-stage). mChemist appears to be a small/niche player relative to these (revenue ~₹1.5 Cr FY25 vs. these players' much larger scale).
Frequently Asked Questions
What does Mchemist Global Private Limited do?
What is the CIN of Mchemist Global Private Limited?
Where is Mchemist Global Private Limited registered?
When was Mchemist Global Private Limited incorporated?
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.